[go: up one dir, main page]

EA200801430A1 - Производные триазола - Google Patents

Производные триазола

Info

Publication number
EA200801430A1
EA200801430A1 EA200801430A EA200801430A EA200801430A1 EA 200801430 A1 EA200801430 A1 EA 200801430A1 EA 200801430 A EA200801430 A EA 200801430A EA 200801430 A EA200801430 A EA 200801430A EA 200801430 A1 EA200801430 A1 EA 200801430A1
Authority
EA
Eurasian Patent Office
Prior art keywords
triazole derivatives
tgf
tumors
kinase
inhibitors
Prior art date
Application number
EA200801430A
Other languages
English (en)
Other versions
EA015254B1 (ru
Inventor
Бертрам Цецанне
Кристиане Амендт
Хартмут Грайнер
Ульрих Грэдлер
Гюнтер Хёльцеманн
Original Assignee
Мерк Патент Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Патент Гмбх filed Critical Мерк Патент Гмбх
Publication of EA200801430A1 publication Critical patent/EA200801430A1/ru
Publication of EA015254B1 publication Critical patent/EA015254B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Новые производные триазола являются ингибиторами киназы TGF-бета рецептора I и могут применяться, в частности, для лечения опухолей.
EA200801430A 2005-12-23 2006-11-24 Производные триазола EA015254B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005061840A DE102005061840A1 (de) 2005-12-23 2005-12-23 Triazolderivate
PCT/EP2006/011277 WO2007079820A1 (de) 2005-12-23 2006-11-24 Triazolderivate

Publications (2)

Publication Number Publication Date
EA200801430A1 true EA200801430A1 (ru) 2008-12-30
EA015254B1 EA015254B1 (ru) 2011-06-30

Family

ID=37973842

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801430A EA015254B1 (ru) 2005-12-23 2006-11-24 Производные триазола

Country Status (15)

Country Link
US (1) US8093240B2 (ru)
EP (2) EP2322527A1 (ru)
JP (1) JP5236490B2 (ru)
KR (1) KR20080090458A (ru)
CN (1) CN101346383B (ru)
AR (1) AR056860A1 (ru)
AU (1) AU2006334899B2 (ru)
BR (1) BRPI0620241A2 (ru)
CA (1) CA2634553C (ru)
DE (1) DE102005061840A1 (ru)
EA (1) EA015254B1 (ru)
ES (1) ES2400728T3 (ru)
IL (1) IL192286A (ru)
WO (1) WO2007079820A1 (ru)
ZA (1) ZA200806358B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2711543C1 (ru) * 2019-02-20 2020-01-17 Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон" Способ лечения экспериментальных химических ожогов и катаракты, смоделированных на кроликах породы Шиншилла

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006051796A1 (de) * 2006-11-03 2008-05-08 Merck Patent Gmbh Triaza-benzo[e]azulenderivate
ES2470681T3 (es) * 2008-07-29 2014-06-24 Merck Patent Gmbh Derivados de Imidazotiadiazol
TW201103939A (en) 2009-03-31 2011-02-01 Arqule Inc Substituted tetrahydropyrazolo-pyrido-azepine compounds
US8541407B2 (en) 2010-03-31 2013-09-24 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
EP2705039B1 (en) * 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
CA2952830C (en) 2014-06-20 2022-11-01 Constellation Pharmaceuticals, Inc. Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide
CN106349241B (zh) * 2015-07-15 2020-04-21 上海翰森生物医药科技有限公司 具有hsp90抑制活性的三唑衍生物及其制备方法和应用
JP7632835B2 (ja) * 2016-05-20 2025-02-19 プレジデント アンド フェローズ オブ ハーバード カレッジ 加齢関連疾患及び症状の遺伝子治療法
CN110172068A (zh) * 2019-06-05 2019-08-27 河南龙湖生物技术有限公司 具有抗肿瘤活性的苯并噻唑类化合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE38931B1 (en) * 1973-03-09 1978-07-05 Lipha Triazolobenzodiazepines
DE2318673A1 (de) 1973-04-13 1974-11-07 Boehringer Sohn Ingelheim Neue substituierte triazolo-1,5benzodiazepine
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
WO1992018505A1 (fr) * 1991-04-23 1992-10-29 Toray Industries, Inc. Derive de triazole tricyclique, production et utilisation de ce derive
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
AU4972900A (en) 1999-04-08 2000-11-14 Arch Development Corporation Use of anti-vegf antibody to enhance radiation in cancer therapy
BR0209939A (pt) 2001-05-24 2004-03-30 Lilly Co Eli Composto ou seu sal, éster ou prodroga farmaceuticamente aceitável, formulação farmacêutica, uso do composto ou de seu sal, éster ou prodroga farmaceuticamente aceitável, e, método para tratar câncer
DE10131430A1 (de) 2001-06-29 2003-01-16 Bosch Gmbh Robert Verfahren zum Verschweißen
GB0127430D0 (en) * 2001-11-15 2002-01-09 Smithkline Beecham Corp Compounds
UA80296C2 (en) * 2002-09-06 2007-09-10 Biogen Inc Imidazolopyridines and methods of making and using the same
OA12927A (en) 2002-09-18 2006-10-13 Pfizer Prod Inc Novel triazole and oxazole compounds as transforming growth factor (TGF) inhibitors.
US7405299B2 (en) * 2002-11-27 2008-07-29 Eli Lilly And Company Compounds as pharmaceutical agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2711543C1 (ru) * 2019-02-20 2020-01-17 Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон" Способ лечения экспериментальных химических ожогов и катаракты, смоделированных на кроликах породы Шиншилла

Also Published As

Publication number Publication date
CN101346383B (zh) 2011-11-30
US8093240B2 (en) 2012-01-10
BRPI0620241A2 (pt) 2011-11-08
CA2634553A1 (en) 2007-07-19
EA015254B1 (ru) 2011-06-30
IL192286A0 (en) 2008-12-29
HK1128022A1 (en) 2009-10-16
JP2009520706A (ja) 2009-05-28
WO2007079820A1 (de) 2007-07-19
EP1966211B1 (de) 2012-12-26
DE102005061840A1 (de) 2007-06-28
IL192286A (en) 2012-10-31
ES2400728T3 (es) 2013-04-11
US20080306042A1 (en) 2008-12-11
ZA200806358B (en) 2009-12-30
KR20080090458A (ko) 2008-10-08
AR056860A1 (es) 2007-10-31
EP2322527A1 (de) 2011-05-18
AU2006334899B2 (en) 2012-06-07
CA2634553C (en) 2014-04-08
JP5236490B2 (ja) 2013-07-17
CN101346383A (zh) 2009-01-14
EP1966211A1 (de) 2008-09-10
AU2006334899A1 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
EA200801430A1 (ru) Производные триазола
EA201000093A1 (ru) Производные пиридазинона
EA200901601A1 (ru) Производные пиридазинона
EA201001005A1 (ru) Производные 2-бензилпиридазинона в качестве ингибиторов мет киназы
ATE432281T1 (de) Pyrrolotriazin-kinasehemmer
EA201100966A1 (ru) Производные пиридазинона
EA200901611A1 (ru) Производные 2-оксо-3-бензил-бензоксазол-2-она и родственные соединения в качестве ингибиторов мет киназы для лечения опухолей
EA200801428A1 (ru) Производные пиридиазинона для лечения опухолей
EA201100334A1 (ru) Бициклические производные триазола для лечения опухолей
EA201000618A1 (ru) 5-цианотиенопиридины для лечения опухолей
NO20070514L (no) Pyrrolotriazin kinase inhibitorer
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
TW200801008A (en) Protein kinase inhibitors
EA200901603A1 (ru) Арил-эфирные производные пиридазинона
EA201001648A1 (ru) Производные пиридазинона
MX2008002104A (es) Derivados de 1-acildihidropirazol.
WO2007067781A3 (en) 9-membered heterobicyclic compounds as inhibitors of protein kinases
CL2007002062A1 (es) Compuestos derivado de [1,2,4]triazolo[4,3-a]piridina, inhibidores de quinasa; composicion farmaceutica; y su uso en el tratamiento del cancer.
EA201200653A1 (ru) Гетариламинохинолины
CL2008001234A1 (es) Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer.
EA201170252A1 (ru) Амидофеноксиндазолы в качестве ингибиторов c-мет
MX354402B (es) Inhibidores de molecula pequeña del dominio de homologia de pleckstrin y metodos para usar los mismos.
DE602007007985D1 (de) Als inhibitoren von proteinkinasen geeignete aminopyrimidine
MX2008001538A (es) Aril piridinas y metodos para su uso.
EA201000550A1 (ru) Производные тиазола

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU